Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia

A Phase 2 Clinical Trial of MW33 Injection in Patients With COVID-19

NCT04627584 ·Status: UNKNOWN ·Phase: PHASE2

Clinical Study of Meplazumab to Treat With Malaria

NCT04327310 ·Status: WITHDRAWN ·Phase: PHASE1

A Clinical Study to Evaluate MW33 Injection

NCT04533048 ·Status: COMPLETED ·Phase: PHASE1

Efficacy of BACMUNE (MV130) in the Prevention of Disease Due to COVID-19 Infection in Healthcare Personnel

NCT04452643 ·Status: WITHDRAWN ·Phase: PHASE3

Exploratory Study to Evaluate the Efficacy of RUTI® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers

NCT04903184 ·Status: COMPLETED ·Phase: PHASE2

Immune Responses After Human Subject Challenge With Sand Fly Bites

NCT01289977 ·Status: COMPLETED

Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis

NCT00111553 ·Status: COMPLETED ·Phase: PHASE1

101-PGC-005 for the Treatment of COVID-19

NCT05656521 ·Status: UNKNOWN ·Phase: PHASE2

Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis

NCT01377974 ·Status: COMPLETED ·Phase: PHASE2

Open-Label Study to Assess Meplazumab in Adult Patients Diagnosed with Plasmodium Falciparum

NCT06040346 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Plasma Immunity of Mild SARS-CoV-2 Omicron and Delta Pandemic in Thailand

NCT05328479 ·Status: COMPLETED

Topical Sm29 in Combination With Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis.

NCT06000514 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety and Efficacy of Low-Dose Pentavalent Antimony for Treatment of Cutaneous Leishmaniasis

NCT00317980 ·Status: COMPLETED ·Phase: PHASE4

Safety Study to Evaluate the Leish-111f + MPL-SE Vaccine in the Prevention of Cutaneous Leishmaniasis in Healthy Subjects Previously Exposed to the Leishmania Parasite

NCT00121849 ·Status: COMPLETED ·Phase: PHASE1

Phase 2 Trial to Evaluate 18-Methoxycoronaridine Efficacy, Safety and Tolerability in Cutaneous Leishmaniasis Patients

NCT03084952 ·Status: UNKNOWN ·Phase: PHASE2

Trial of Miltefosine in Cutaneous Leishmaniasis (Brazil)

NCT00600548 ·Status: COMPLETED ·Phase: PHASE2

Antihelminthic Therapy Combined With Antimony in the Treatment of Cutaneous Leishmaniasis

NCT00469495 ·Status: COMPLETED ·Phase: NA

Immuno-bridging Study of COVID-19 Protein Subunit Recombinant Vaccine

NCT05433285 ·Status: COMPLETED ·Phase: PHASE3

Clinical Trial to Evaluate the Safety and Immunogenicity of the Vivaxin Vaccine for Malaria Caused by Plasmodium Vivax."

NCT07172724 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal Leishmaniasis

NCT00111514 ·Status: COMPLETED ·Phase: PHASE1

Pilot Study: Oral Treatment of American Tegumentary Leishmaniasis (Cutaneous and Mucosal Forms) in the Elderly

NCT06040489 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Pan-Malaria Transmission-Blocking Vaccine AnAPN1

NCT05905432 ·Status: COMPLETED ·Phase: PHASE1

Controlled Human Malarial Infection by Intravenous Injection of Plasmodium Falciparum Sporozoites in Non-Immune Adults

NCT01624961 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil

NCT01310738 ·Status: TERMINATED ·Phase: PHASE4

A Clinical Trial to Evaluate the Safety, Efficacy and Immune Responses After Vaccination With an Investigational RNA-based Vaccine Against Malaria

NCT06069544 ·Status: COMPLETED ·Phase: PHASE1/PHASE2